A61K 38/1745
C-reactive proteins
Official title: {C-reactive proteins}
A61K38/1745 (C-reactive proteins) appears on 1 US grants and 10 published applications in this corpus.
Search patents in A61K- Granted patents
- 1
- Published applications
- 10
- Assignees
- 7
- Inventors
- 10
- Latest grant
- 11 Sep 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 4 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Product suitable for the treatment of tear film deficiency in dry eye disease and a method for manufacturing the product8 Jan 2026US 2026/0007722 A1Sanaplas GmbH
- Methods of preventing or treating neurogenic shock17 Dec 2020US 2020/0390800 A1Ramot at Tel-Aviv University Ltd.
- Conformationally stable analogs of the response selective c5a agonist ep678 Mar 2018US 2018/0066018 A1Board of Regents of the University of Nebraska
- Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis21 Mar 2013US 2013/0072445 A9
- Development of c-reactive protein mutant with improved therapeutic benefit in immune thrombocytopenia and lupus nephritis23 Jun 2011US 2011/0152202 A1
Most cited
By later US patents